A monoclonal antibody against HER-2 (trastuzumab) for metastatic breast cancer: a model-based cost-effectiveness analysis.

Source:http://linkedlifedata.com/resource/pubmed/id/15849222

Download in:

View as

General Info

PMID
15849222